[Skip to Content]
[Skip to Content Landing]
March 1978

Erythromycin Estolate Hepatotoxicity

Author Affiliations

Children's Memorial Hospital 2300 Children's Plaza Chicago, IL 60614

Am J Dis Child. 1978;132(3):320. doi:10.1001/archpedi.1978.02120280104025

A recent review of erythromycin1 stated that of 506 cases of cholestatic jaundice following erythromycin estolate administration reported between 1961-1973, only 12 (2%) occurred in children younger than 12 years of age. During the same period an estimated 30 million courses of therapy with a liquid form of estolate were prescribed.

We report the case of a child in whom cholestatic jaundice developed and who was seen as an acute surgical emergency after erythromycin estolate administration. A percutaneous liver biopsy specimen demonstrated changes consistent with a hypersensitivity drug reaction.

Report of a Case.—A 7-year-old boy was hospitalized with abdominal pain, rash, and fever of two days' duration. Four weeks prior to admission to the hospital his mother administered two 250-mg tablets of erythromycin estolate for treatment of a sore throat. Three days prior to admission an upper respiratory infection again developed and the patient was given erythromycin estolate

First Page Preview View Large
First page PDF preview
First page PDF preview